Drugs / Priorix-Tetra
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT00892775 | Jun 2009 → Sep 2010 | measles, mumps infectious disease, rubella, varicella zoster infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00578175 | Nov 2007 → Feb 2009 | chickenpox, measles, mumps infectious disease, rubella | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 35 trials | ||||||
| Phase 3 | NCT01506193 | Feb 2012 → Feb 2014 | chickenpox, measles, mumps infectious disease, rubella | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00969436 | Nov 2009 → Feb 2011 | measles, mumps infectious disease, rubella, varicella zoster infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00751348 | Oct 2008 → May 2010 | measles, mumps infectious disease, rubella, varicella zoster infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00474266 | Jun 2007 → Feb 2008 | meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00226499 | Sep 2005 → Oct 2006 | chickenpox | GlaxoSmithKline | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00871000 Background | Apr → Nov 2009 | diphtheria, poliomyelitis, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Priorix-Tetra | “Subjects received 2 doses of Priorix-Tetra® vaccine, 1 at Day 0 and 1 at Month 6, administered subcutaneously in the left anterolateral thigh.” NCT00969436 ↗8“Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children” NCT00474266 ↗ |
| Known as | 208136 | “Biological: Priorix-Tetra™ (MMRV vaccine 208136)” NCT00578175 ↗ |
| Modality | Vaccine | “combined measles-mumps-rubella-varicella vaccine” NCT00226499 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT00226499 ↗ |